Fee Proposal for Drugs and Medical Devices: Closed consultation
From Health Canada
Current status: Closed
This consultation ran from October 11, 2017 to January 4, 2018
See the Revised Fee Proposal for Drugs and Medical Devices (May 2018)
The goal of the consultation was to update fees for human and veterinary drug and medical device regulatory programs, and as well as obtain feedback from stakeholders on the Fee Proposal for Drugs and Medical Devices.
Who was the focus of this consultation?
The Government of Canada engaged with:
- Industry stakeholders, including: Medical Devices, Disinfectants, Generic Drugs, Innovators / Biologic Drugs, Over-the-Counter (Non-prescription Drugs), Radiopharmaceutical Drugs and Veterinary Drugs
- Interested members of the public and consumers
What we heard
As a result of this consultation, Health Canada published a Revised Fee Proposal for Drugs and Medical Devices, which includes stakeholders' feedback and Health Canada's responses.
Cost Recovery Renewal Initiative
Resource Management and Operations Directorate
Health Products and Food Branch, Health Canada
250 Lanark Avenue
Ottawa, ON K1Z1G4
Report a problem or mistake on this page
- Date modified: